PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B-Reference-Cited by-同舟云学术

PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B

Published:2024-01 Issue:1 Volume:80 Page:20-30
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Chun Ho Soo^ORCID,Papatheodoridis George V.^ORCID,Lee Minjong,Lee Hye Ah,Kim Yeong Hwa,Kim Seo Hyun,Oh Yun-Seo,Park Su Jin,Kim Jihye,Lee Han Ah,Kim Hwi Young^ORCID,Kim Tae Hun,Yoon Eileen L.,Jun Dae Won,Ahn Sang Hoon,Sypsa Vana,Yurdaydin Cihan^ORCID,Lampertico Pietro,Calleja Jose Luis,Janssen Harry LA.,Dalekos George N.^ORCID,Goulis John,Berg Thomas^ORCID,Buti Maria,Kim Seung Up^ORCID,Kim Yoon Jun^ORCID

Funder

Ministry of Science, ICT and Future Planning

National Research Foundation of Korea

Ministry of Education

Publisher

Elsevier BV

Subject

Hepatology

Reference24 articles.

1. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;J Hepatol,2017

2. KASL clinical practice guidelines for management of chronic hepatitis B;Clin Mol Hepatol,2022

3. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B;Choi;J Clin Invest,2022

4. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients;Kim;Aliment Pharmacol Ther,2020

5. Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?;Wong;J Hepatol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A closer look at the innovative PAGED-B score;Journal of Hepatology;2024-09

2. Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis;JHEP Reports;2024-07

3. Evaluation of PAGE-B Score for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients: Reliability, Validity, and Responsiveness;Biomedicines;2024-06-05

4. Editorial: High qHBsAg—is it a good or bad signal?;Alimentary Pharmacology & Therapeutics;2024-04-21

5. PAGE-B with Moderate HBV DNA Levels Predicts Risk of Hepatocellular Carcinoma among Patients at Phase Change from Immuno-tolerant Phase to Immune-active Phase in HBeAg-Positive Chronic Hepatitis B;The Korean Journal of Gastroenterology;2023-12-25